Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
B Shariat-Madar1, D Kolte2, A Verlangieri2, Z Shariat-Madar21College of Literature, Science, and the Arts, University of Michigan, Ann Arbor MI, USA; 2School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS, USAAbstract: Recently, we serendipitously discovered that...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-04-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/prolylcarboxypeptidase-prcp-as-a-new-target-for-obesity-treatment-peer-reviewed-article-DMSO |